BETWEENContract Manufacturing Agreement • March 15th, 2006 • Celgene Corp /De/ • Pharmaceutical preparations • New York
CONTRACT MANUFACTURING AGREEMENT dated as of July 2, 2023 by and between BorgWarner (Shanghai) Automobile Fuel Systems Co., Ltd. and BorgWarner Poland sp. z o.oContract Manufacturing Agreement • July 7th, 2023 • Phinia Inc. • Motor vehicle parts & accessories
ContractContract Manufacturing Agreement • April 5th, 2019 • TransMedics Group, Inc. • Electromedical & electrotherapeutic apparatus • London
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
RECITALSContract Manufacturing Agreement • March 15th, 2004 • Conceptus Inc • Surgical & medical instruments & apparatus • California
AMENDMENT NO. 5 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 5 (the “Amendment”) is made as of October 13 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, Inc. with offices at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin Pharmaceuticals, LLC”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • March 1st, 2019 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations
This Contract Manufacturing Agreement is made by and between (1) Fresenius Kabi Austria GmbH, having its registered office at Hafnerstrasse 36, A-8055 Graz, Austria (“FRESENIUS”) and (2) AMAG Pharmaceuticals, Inc., a Delaware corporation having an office at 1100 Winter Street, Waltham, MA 02451, U.S.A. (“COMPANY”), effective as of September 1, 2018 (the “Effective Date”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 8th, 2008 • Prestige Brands Holdings, Inc. • Pharmaceutical preparations • Groningen
Medtech Products Inc., a company organized and existing under the laws of the State of Delaware, USA, having its principal place of business at 90 North Broadway, Irvington, New York 10533, together with any affiliate thereof, hereinafter called “Medtech”;
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • January 28th, 2019 • Pioneer Power Solutions, Inc. • Power, distribution & specialty transformers • California
This CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made as of January 22, 2019, by and between Cleanspark, Inc., a Nevada corporation (“Cleanspark”) and Pioneer Power Solutions, Inc., a Delaware corporation (“Pioneer”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 23rd, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • Washington
This CONTRACT MANUFACTURING AGREEMENT (the "Agreement") is entered into as of October 16, 2000 (the "Effective Date"), by and between ICOS Corporation ("ICOS"), a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 22021 20th Avenue SE, Bothell, WA 98021 USA and Seattle Genetics, Inc. ("SGI"), a corporation organized and existing under the laws of the State of Delaware and having its principal place of business at 22215 26th Avenue S.E., Suite 3000, Bothell, WA 98021.
Certain portions of this Exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K and, where applicable, have been marked with “[***]” to indicate where redactions have been made. CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • September 30th, 2022 • LiveWire Group, Inc. • Motorcycles, bicycles & parts • Delaware
This CONTRACT MANUFACTURING AGREEMENT (this “Agreement”) is made as of September 26, 2022 (the “Effective Date”), by and between Harley-Davidson Motor Company Group, LLC, a limited liability company formed in Wisconsin, United States of America (“HD”), and LiveWire EV, LLC, a Delaware limited liability company (“LiveWire”). HD and LiveWire are each a “Party” and are sometimes referred to herein collectively as the “Parties.”
RECITALSContract Manufacturing Agreement • March 28th, 2003 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
GES") - 1 - 2 CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • August 10th, 2001 • Global Election Systems Inc • Services-computer integrated systems design • Ohio
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • June 27th, 2014 • Zep Inc. • Specialty cleaning, polishing and sanitation preparations • Georgia
This CONTRACT MANUFACTURING AGREEMENT (“Agreement”) is entered into as of May 30, 2014 (“Effective Date”) by Amrep, Inc., a company organized under the laws of the State of Delaware with its principal place of business at c/o Zep Inc., 1310 Seaboard Industrial Blvd., Atlanta, GA 30318 and doing business as “Zep Commercial Sales & Service” (“Zep”), and Apollo Technologies, Inc., a company organized under the laws of the State of Georgia with its principal place of business at 1850 South Cobb Industrial Blvd., Smyrna, GA 30082 (“Apollo”) (Zep and Apollo are referred to collectively as the “Parties”). As used in this document the term “Agreement” shall include all exhibits attached hereto and all supply orders issued hereunder.
AMENDMENT NO. 4 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 4 (the “Amendment”) is made as of 23rd June 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with a principal place of business at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
AMENDMENT TO CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • January 20th, 2005 • Dyadic International Inc • Services-commercial physical & biological research
AMENDMENT NO. 3 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 3 (the “Amendment”) is made as of 8th July 2013 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with offices at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
AMENDMENT NO. 4 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
THIS AMENDMENT NO. 4 (the “Amendment”) is made as of 23rd June 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, LLC (formerly known as and successor in interest to Amylin Pharmaceuticals, Inc.) with a principal place of business at 9625 Towne Centre Drive, San Diego, California 92121, USA (“Amylin”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • June 20th, 2006 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This CONTRACT MANUFACTURING AGREEMENT (this “Agreement”) is made and entered into this 5th day of March, 2003 (the “Effective Date”), by and between BOSTON SCIENTIFIC CORPORATION (“BSC”) a Delaware corporation, and OSIRIS ACQUISITION II, INC. (“Osiris”), a Delaware corporation (each a “Party,” and collectively, the “Parties”).
CONTRACT MANUFACTURING AGREEMENT AMONG ONYX PHARMACEUTICALS, INC., ONYX PHARMACEUTICALS INTERNATIONAL GMBH AND CAMBRIDGE MAJOR LABORATORIES, INC. CONFIDENTIALContract Manufacturing Agreement • February 28th, 2013 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Contract Manufacturing Agreement (the “Agreement”) is entered into as of the 25th day of June, 2012 (“Effective Date”) by and among CAMBRIDGE MAJOR LABORATORIES, INC., a Wisconsin corporation, having its principal address at W130 N10497 Washington Drive, Germantown, Wisconsin 53022 (“CAMBRIDGE”), ONYX PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business at 249 East Grand Avenue, South San Francisco, Califomia 94080 and ONYX PHARMACEUTICALS INTERNATIONAL GMBH, a Swiss limited liability corporation, having its principal place of business at Dammstrasse 19, 6300 Zug, Switzerland (collectively, herein referred to as “ONYX”). CAMBRIDGE and ONYX may each be referred to herein as a “Party” and collectively, the “Parties.”
Contract Manufacturing AgreementContract Manufacturing Agreement • May 10th, 2012 • Medicines Co /De • Pharmaceutical preparations • Delaware
WHEREAS, MDCO wishes to have the Product manufactured, packaged, tested, and supplied to it by APP for commercial sales, and APP wishes to manufacture, package, test and supply to MDCO the Product for commercial sales, in accordance with the terms and conditions of this Agreement; and
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • November 7th, 2007 • Fabrinet • New York
THIS CONTRACT MANUFACTURING AGREEMENT is made effective as of November 15, 2004 (Effective Date) between JDS Uniphase Corporation, having offices at 1768 Automation Parkway, San Jose, California, 95131, on behalf of itself and its affiliates and subsidiaries (collectively, JDSU) and Fabrinet having offices at 294 Moo 8, Vibhavadi Rangsit Road Kookot, Lamlooka Pathumthani, Thailand 12130, on behalf of itself and its affiliates and subsidiaries (collectively, Supplier).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • April 6th, 2022 • Embecta Corp. • Surgical & medical instruments & apparatus • Delaware
This Contract Manufacturing Agreement (this “Agreement”) is made and entered into as of March 31, 2022, with effectiveness as of 12:01 a.m., New York City time, on April 1, 2022 (the “Effective Date”) by and between Becton, Dickinson and Company, a New Jersey corporation (“BD”), and Embecta Corp., a Delaware corporation (“SpinCo”). Parent and SpinCo are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CONTRACT MANUFACTURING AGREEMENT By and Among STR Solar (Hong Kong), Limited ZheJiang FeiYu Photo-Electrical Science & Technology Co., Ltd. and Zhejiang Xiesheng Group Co., Ltd.Contract Manufacturing Agreement • May 7th, 2014 • STR Holdings, Inc. • Unsupported plastics film & sheet
THIS CONTRACT MANUFACTURING AGREEMENT, made as of 13 JAN, 2014, by and between STR Solar (Hong Kong), Limited, a company organized and existing under the laws of Hong Kong Special Administrative Region (hereinafter called “Hong Kong”) of the People’s Republic of China (hereinafter called “China”), and having its office and place of business at Room D, 32nd Floor, Lippo Centre, Tower 1, 89 Queensway, Hong Kong(hereinafter called “STR”), ZheJiang FeiYu Photo-Electrical Science & Technology Co., Ltd., a company organized and existing under the laws of China, and having its office and place of business at No. 6 Xinghang 1 Road Industry Functional Zone, Hangbu Town, Ke Cheng District, Quzhou City, Zhejiang Province, China_(“FeiYu”), and Zhejiang Xiesheng Group Co., Ltd., a company organized and existing under the laws of China, and having its office and place of business at No. 119, West Zijing Road, Quzhou City, Zhejiang Province, China (“Xiesheng”; .together with FeiYu hereinafter called
Contract Manufacturing AgreementContract Manufacturing Agreement • October 30th, 2019 • Emcore Corp • Semiconductors & related devices • Hong Kong
This Contract Manufacturing Agreement, dated as of October 25, 2019 (the “Agreement”), is entered into by and between Shenzhen Hytera Communications Co., Ltd. , a corporation formed under the laws of the P.R.C. (“SHCCL”), together with Hytera Communications (Hong Kong) Company Limited, a limited liability company incorporated in Hong Kong (registration number 39005087-000-03-19-2) having an address at Unit 223 2/F Hi-Tech Centre 9 Choi Yuen Road Sheng Shui Nt Hong Kong (“Hytera HK”, and both SHCCL and Hytera HK are collectively referred to in this Agreement as “Hytera”, or “Sellers”), and EMCORE Corporation, a New Jersey corporation having an address at 2015 Chestnut St., Alhambra, CA 91803 (“EMCORE”, or “Buyer”, and together with Hytera, the "Parties", and each, a "Party").
Contract Manufacturing AgreementContract Manufacturing Agreement • June 21st, 2021 • Applied UV, Inc. • Electric lighting & wiring equipment • Delaware
This Contract Manufacturing Agreement (the “Agreement”) is entered into as of January 1, 2021 (the “Effective Date”), by and between KES SCIENCE & TECHNOLOGY INC., a Georgia corporation, at 3625 Kennesaw North Industrial Parkway, Kennesaw, Georgia 30144 (“KES”), and AKIDA HOLDING, LLC, a Florida limited liability company, at 2300 Marshpoint Road, Suite 202, Neptune Beach, Florida 32266 (“Akida”). KES and Akida are each a “Party” and collectively, the “Parties.”
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • February 25th, 2020 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations
Unless elsewhere defined in this Agreement, each of the capitalized terms used in this Agreement (other than the names of the Parties and the headings of the Sections) shall have the meanings indicated below. Such meanings shall apply equally to all forms of such terms, including singular and plural forms, unless otherwise clearly indicated.
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • July 2nd, 2020 • TRANS LUX Corp • Miscellaneous manufacturing industries • Missouri
This Contract Manufacturing Agreement (the “Agreement”) is effective as of June 4, 2020 (“Effective Date”) by and between Trans-Lux Corporation, a corporation formed under the laws of the state of Delaware, and its wholly owned subsidiary, Fairplay Corporation, a company incorporated under the laws of Iowa, and having its head office at 135 East 57th Street, 14th Floor, New York, New York 10022 (hereinafter referred to as “Fairplay” and/or “TNLX” as the context may require), and Craftsmen Industries, Inc., a corporation incorporated under the laws of the State of Missouri, and having its office at 3101 Elm Point Industrial Drive, St. Charles, Missouri 63301-4338 (hereinafter referred to as “Craftsmen”)Fairplay and Craftsmen may be individually referred to as a “Party” or collectively as the “Parties”.
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • October 31st, 2015
AMENDED AND RESTATED CONTRACT MANUFACTURING AGREEMENT Between OSG NORWICH PHARMACEUTICALS, INC. And ALLENDALE PHARMACEUTICALS, INC. For US FDA APPROVED TODAY SPONGEContract Manufacturing Agreement • February 26th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances • New York
THIS AMENDED AND RESTATED CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made this 8th day of March, 2006 (the “Agreement Date”), by and between ALLENDALE PHARMACEUTICALS, INC. (hereinafter known as “Allendale”), a Delaware corporation with a principal place of business at 11 Franklin Turnpike, Allendale, NJ 07401, and OSG NORWICH PHARMACEUTICALS, INC. (hereinafter known as “NPI”), a Delaware corporation with a principal place of business at 6826 State Highway 12, Norwich, NY 13815.
November 1, 2005 CONTRACT MANUFACTURING AGREEMENT between OSG NORWICH PHARMACEUTICALS, INC. and JDS PHARMACEUTICALS, LLC.Contract Manufacturing Agreement • November 9th, 2007 • Noven Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made this 1st.day of November, 2005 (the “Agreement Date”), by and between JDS Pharmaceuticals, LLC. (“JDS”), a Delaware Limited Liability Company with a principal place of business at 122 East 42nd. Street New York, NY 10168 USA, and OSG NORWICH PHARMACEUTICALS, INC (“NPI”), a Delaware corporation with a principal place of business at 6826 State Highway 12, Norwich, NY 13815 USA.
AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • April 20th, 2021 • Honest Company, Inc. • Retail-catalog & mail-order houses
This Amendment No. 2 (the “Amendment”) is made as of 1st day of May, 2020 (the “Effective Date”) to the Second Amended and Restated Contract Manufacturing Agreement entered into as of January 1, 2019 (the “Agreement”), as amended to date, by and between The Honest Company, Inc., a Delaware company (“Honest’’) and Valor Brands LLC, a.k.a. Ontex North America, a limited liability company (“Supplier”). Capitalized words used herein and not defined shall have the meaning ascribed to them in the Agreement.
Contract Manufacturing AgreementContract Manufacturing Agreement • November 4th, 2005 • Curon Medical Inc • Electromedical & electrotherapeutic apparatus • California
This Contract Manufacturing Agreement (the “Agreement”) is made as of October 31, 2005 (the “Effective Date”) by and between Life Science Outsourcing, its principal offices being located at 830 Challenger Street, Brea, CA 92821 (“LSO”) and Curon Medical, Inc, its principal offices being located at 46117 Landing Parkway, Fremont, CA 94538 (“Buyer”).
CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • November 7th, 2001 • Chiron Corp • Pharmaceutical preparations
THIS CONTRACT MANUFACTURING AGREEMENT (the "Agreement") is made and entered into as of July 26, 2001 ("Date of Agreement"), by and between:
THIRD AMENDMENT CONTRACT MANUFACTURING AGREEMENTContract Manufacturing Agreement • March 15th, 2004 • Genzyme Corp • Biological products, (no disgnostic substances)
Contract Manufacturing AgreementContract Manufacturing Agreement • August 14th, 2003 • Vision Sciences Inc /De/ • Electromedical & electrotherapeutic apparatus • Tel-Aviv
Vision-Sciences, Inc., a Delaware (U.S.A.) corporation, having its principal place of business at 9 Strathmore Road, Natick, Massachusetts 01760, U.S.A., Fax No. +1-508-650-9976 (the “Company”);
